BackKymera Therapeutics Overview

Kymera Therapeutics Other Current Liabilities

Track Kymera Therapeutics's other current liabilities ($49M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$48.71M
↑ 73.40% YoYΔ $20.62M vs prior year quarter

Peer trimmed avg / median

Loading

Kymera Therapeutics Other Current Liabilities History

Loading

Kymera Therapeutics vs. peers: Other Current Liabilities Comparison

Loading

Kymera Therapeutics Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Kymera Therapeutics (KYMR) FAQ

As of the most recent data (June 2026), KYMR shows a other current liabilities of $49M. That compares with $28M in the prior-year period — up 73.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, KYMR's other current liabilities is now $49M (was $28M) — a 73.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Kymera Therapeutics is outperforming or lagging.

Tracking KYMR's other current liabilities over time shows whether Kymera Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $49M That compares with $28M in the prior-year period — up 73.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Kymera Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $49M) with ownership activity and broader fundamentals.

Kymera Therapeutics's other current liabilities is $49M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.